Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Primary Care Audit of Global Risk Management (PARADIGM)

This study has been completed.
Sponsor:
Collaborator:
AstraZeneca
Information provided by (Responsible Party):
Dr. Milan Gupta, Canadian Cardiovascular Research Network
ClinicalTrials.gov Identifier:
NCT00950703
First received: July 31, 2009
Last updated: October 13, 2015
Last verified: October 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2015
  Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)